Nutritional status in young children prior to the malaria transmission season in Burkina Faso and Mali, and its impact on the incidence of clinical malaria.


Journal

Malaria journal
ISSN: 1475-2875
Titre abrégé: Malar J
Pays: England
ID NLM: 101139802

Informations de publication

Date de publication:
22 Jun 2021
Historique:
received: 16 10 2020
accepted: 07 06 2021
entrez: 23 6 2021
pubmed: 24 6 2021
medline: 6 10 2021
Statut: epublish

Résumé

Malaria and malnutrition remain major problems in Sahel countries, especially in young children. The direct effect of malnutrition on malaria remains poorly understood, and may have important implications for malaria control. In this study, nutritional status and the association between malnutrition and subsequent incidence of symptomatic malaria were examined in children in Burkina Faso and Mali who received either azithromycin or placebo, alongside seasonal malaria chemoprevention. Mid-upper arm circumference (MUAC) was measured in all 20,185 children who attended a screening visit prior to the malaria transmission season in 2015. Prior to the 2016 malaria season, weight, height and MUAC were measured among 4149 randomly selected children. Height-for-age, weight-for-age, weight-for-height, and MUAC-for-age were calculated as indicators of nutritional status. Malaria incidence was measured during the following rainy seasons. Multivariable random effects Poisson models were created for each nutritional indicator to study the effect of malnutrition on clinical malaria incidence for each country. In both 2015 and 2016, nutritional status prior to the malaria season was poor. The most prevalent form of malnutrition in Burkina Faso was being underweight (30.5%; 95% CI 28.6-32.6), whereas in Mali stunting was most prevalent (27.5%; 95% CI 25.6-29.5). In 2016, clinical malaria incidence was 675 per 1000 person-years (95% CI 613-744) in Burkina Faso, and 1245 per 1000 person-years (95% CI 1152-1347) in Mali. There was some evidence that severe stunting was associated with lower incidence of malaria in Mali (RR 0.81; 95% CI 0.64-1.02; p = 0.08), but this association was not seen in Burkina Faso. Being moderately underweight tended to be associated with higher incidence of clinical malaria in Burkina Faso (RR 1.27; 95% CI 0.98-1.64; p = 0.07), while this was the case in Mali for moderate wasting (RR 1.27; 95% CI 0.98-1.64; p = 0.07). However, these associations were not observed in severely affected children, nor consistent between countries. MUAC-for-age was not associated with malaria risk. Both malnutrition and malaria were common in the study areas, high despite high coverage of seasonal malaria chemoprevention and long-lasting insecticidal nets. However, no strong or consistent evidence was found for an association between any of the nutritional indicators and the subsequent incidence of clinical malaria.

Sections du résumé

BACKGROUND BACKGROUND
Malaria and malnutrition remain major problems in Sahel countries, especially in young children. The direct effect of malnutrition on malaria remains poorly understood, and may have important implications for malaria control. In this study, nutritional status and the association between malnutrition and subsequent incidence of symptomatic malaria were examined in children in Burkina Faso and Mali who received either azithromycin or placebo, alongside seasonal malaria chemoprevention.
METHODS METHODS
Mid-upper arm circumference (MUAC) was measured in all 20,185 children who attended a screening visit prior to the malaria transmission season in 2015. Prior to the 2016 malaria season, weight, height and MUAC were measured among 4149 randomly selected children. Height-for-age, weight-for-age, weight-for-height, and MUAC-for-age were calculated as indicators of nutritional status. Malaria incidence was measured during the following rainy seasons. Multivariable random effects Poisson models were created for each nutritional indicator to study the effect of malnutrition on clinical malaria incidence for each country.
RESULTS RESULTS
In both 2015 and 2016, nutritional status prior to the malaria season was poor. The most prevalent form of malnutrition in Burkina Faso was being underweight (30.5%; 95% CI 28.6-32.6), whereas in Mali stunting was most prevalent (27.5%; 95% CI 25.6-29.5). In 2016, clinical malaria incidence was 675 per 1000 person-years (95% CI 613-744) in Burkina Faso, and 1245 per 1000 person-years (95% CI 1152-1347) in Mali. There was some evidence that severe stunting was associated with lower incidence of malaria in Mali (RR 0.81; 95% CI 0.64-1.02; p = 0.08), but this association was not seen in Burkina Faso. Being moderately underweight tended to be associated with higher incidence of clinical malaria in Burkina Faso (RR 1.27; 95% CI 0.98-1.64; p = 0.07), while this was the case in Mali for moderate wasting (RR 1.27; 95% CI 0.98-1.64; p = 0.07). However, these associations were not observed in severely affected children, nor consistent between countries. MUAC-for-age was not associated with malaria risk.
CONCLUSIONS CONCLUSIONS
Both malnutrition and malaria were common in the study areas, high despite high coverage of seasonal malaria chemoprevention and long-lasting insecticidal nets. However, no strong or consistent evidence was found for an association between any of the nutritional indicators and the subsequent incidence of clinical malaria.

Identifiants

pubmed: 34158054
doi: 10.1186/s12936-021-03802-2
pii: 10.1186/s12936-021-03802-2
pmc: PMC8220741
doi:

Substances chimiques

Antimalarials 0
Azithromycin 83905-01-5

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

274

Subventions

Organisme : Medical Research Council
ID : MR/K007319/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R010161/1
Pays : United Kingdom
Organisme : Joint Global Health Trials scheme (which includes the U.K. Medical Research Council, Department for International Development, National Institute for Health Research, and the Wellcome Trust)
ID : MR/K007319/1
Organisme : Jointly funded by the UK Medical Research Council (MRC) and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement, which is also part of the EDCTP2 programme supported by the European Union
ID : MR/R010161/1

Références

PLoS One. 2018 Jan 11;13(1):e0190983
pubmed: 29324840
Monogr Ser World Health Organ. 1968;57:3-329
pubmed: 4976616
J Infect Dis. 2003 Feb 1;187(3):467-76
pubmed: 12552431
PLoS Med. 2020 Aug 21;17(8):e1003214
pubmed: 32822362
Malar J. 2015 Sep 17;14:346
pubmed: 26377094
Trop Med Int Health. 2005 Oct;10(10):1047-59
pubmed: 16185240
Am J Trop Med Hyg. 2009 Feb;80(2):202-8
pubmed: 19190214
Matern Child Nutr. 2012 Jan;8(1):130-3
pubmed: 21951349
PLoS One. 2019 Jan 25;14(1):e0210692
pubmed: 30682069
Malar J. 2011 Aug 04;10:223
pubmed: 21816032
J Infect Dis. 2000 Sep;182 Suppl 1:S37-53
pubmed: 10944483
N Engl J Med. 2019 Jun 06;380(23):2197-2206
pubmed: 30699301
Pan Afr Med J. 2014 Mar 05;17:161
pubmed: 25120874
J Trop Pediatr. 2002 Apr;48(2):78-83
pubmed: 12022433
Bull World Health Organ. 1997;75(1):11-8
pubmed: 9141745
PLoS One. 2017 May 11;12(5):e0177338
pubmed: 28494007
BMC Med. 2018 Oct 29;16(1):186
pubmed: 30371344
Trop Med Int Health. 1999 Feb;4(2):120-30
pubmed: 10206266
Paediatr Int Child Health. 2014 Dec;34 Suppl 1:S1-S29
pubmed: 25475887
JAMA. 2005 Aug 3;294(5):591-7
pubmed: 16077053
Trop Med Int Health. 2020 Jun;25(6):740-750
pubmed: 32166877
Lancet. 2019 Jul 27;394(10195):322-331
pubmed: 31229234
Trop Med Int Health. 2003 Jun;8(6):507-11
pubmed: 12791055
Malar J. 2012 Mar 27;11:90
pubmed: 22453048
Am J Clin Nutr. 1998 Sep;68(3):734-41
pubmed: 9734755

Auteurs

Mariken de Wit (M)

London School of Hygiene and Tropical Medicine, London, UK. mariken.dewit@wur.nl.

Matthew Cairns (M)

London School of Hygiene and Tropical Medicine, London, UK.

Yves Daniel Compaoré (YD)

Institut de Recherche en Sciences de La Santé, Bobo-Dioulasso, Burkina Faso.

Issaka Sagara (I)

Malaria Research and Training Centre, University of Science, Techniques, and Technologies of Bamako, Bamako, Mali.

Irene Kuepfer (I)

London School of Hygiene and Tropical Medicine, London, UK.

Issaka Zongo (I)

Institut de Recherche en Sciences de La Santé, Bobo-Dioulasso, Burkina Faso.

Amadou Barry (A)

Malaria Research and Training Centre, University of Science, Techniques, and Technologies of Bamako, Bamako, Mali.

Modibo Diarra (M)

Malaria Research and Training Centre, University of Science, Techniques, and Technologies of Bamako, Bamako, Mali.

Amadou Tapily (A)

Malaria Research and Training Centre, University of Science, Techniques, and Technologies of Bamako, Bamako, Mali.

Samba Coumare (S)

Malaria Research and Training Centre, University of Science, Techniques, and Technologies of Bamako, Bamako, Mali.

Ismaila Thera (I)

Malaria Research and Training Centre, University of Science, Techniques, and Technologies of Bamako, Bamako, Mali.

Frederic Nikiema (F)

Institut de Recherche en Sciences de La Santé, Bobo-Dioulasso, Burkina Faso.

R Serge Yerbanga (RS)

Institut de Recherche en Sciences de La Santé, Bobo-Dioulasso, Burkina Faso.

Rosemonde M Guissou (RM)

Institut de Recherche en Sciences de La Santé, Bobo-Dioulasso, Burkina Faso.

Halidou Tinto (H)

Institut de Recherche en Sciences de La Santé, Bobo-Dioulasso, Burkina Faso.

Alassane Dicko (A)

Malaria Research and Training Centre, University of Science, Techniques, and Technologies of Bamako, Bamako, Mali.

Daniel Chandramohan (D)

London School of Hygiene and Tropical Medicine, London, UK.

Brian Greenwood (B)

London School of Hygiene and Tropical Medicine, London, UK.

Jean Bosco Ouedraogo (JB)

Institut de Recherche en Sciences de La Santé, Bobo-Dioulasso, Burkina Faso.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH